Search Results - "Crescenzo, Ramona"
-
1
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
Published in Nature communications (30-01-2017)“…Peripheral T-cell lymphomas (PTCL) are aggressive diseases with poor response to chemotherapy and dismal survival. Identification of effective strategies to…”
Get full text
Journal Article -
2
The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation
Published in Communications biology (03-11-2022)“…Aberrant DNA methylation patterns are a prominent feature of cancer. Methylation of DNA is mediated by the DNA methyltransferase (DNMT) protein family, which…”
Get full text
Journal Article -
3
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes
Published in Oncotarget (29-11-2016)“…Anaplastic large cell lymphomas (ALCL) represent a peripheral T-cell lymphoma subgroup, stratified based on the presence or absence of anaplastic lymphoma…”
Get full text
Journal Article -
4
Correction: Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
Published in Nature communications (20-02-2017)“…Nature Communications 8: Article number: 14290 (2017); Published: 30 January 2017; Updated: 20 February 2017 The original version of this Article contained an…”
Get full text
Journal Article -
5
Anaplastic lymphoma kinase inhibitors
Published in Current opinion in pharmacology (01-08-2015)“…Graphical abstract ALK signaling: Wild type (WT) ALK receptor (ALKr) requires ligand dimerization to trigger cellular signaling, conversely mutated ALKr and…”
Get full text
Journal Article -
6
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Published in Cancer cell (13-04-2015)“…A systematic characterization of the genetic alterations driving ALCLs has not been performed. By integrating massive sequencing strategies, we provide a…”
Get full text
Journal Article -
7
SETDB1 Suppresses Interferon Responses and NK Cell-Mediated Immunosurveillance Specifically in Monocytic AML
Published in Blood (02-11-2023)“…Acute myeloid leukemia (AML) with monocytic differentiation (monocytic AML) responds poorly to current treatments, including venetoclax-based therapy. To…”
Get full text
Journal Article -
8
Abstract 2885: Somatic mutation of STAT3 leads to the preferential Th17 differentiation in human naïve CD4-positive cells and favor TCR-mediated proliferation
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Intro: Mature Th17 lymphocytes play a key role in the host defenses against bacteria and fungi although unchecked Th17 activation can lead to…”
Get full text
Journal Article -
9
Abstract 2885: Somatic mutation of STAT3 leads to the preferential Th17 differentiation in human nave CD4-positive cells and favor TCR-mediated proliferation
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Intro: Mature Th17 lymphocytes play a key role in the host defenses against bacteria and fungi although unchecked Th17 activation can lead to autoimmune…”
Get full text
Journal Article -
10
SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation
Published in Cell reports (Cambridge) (27-08-2024)“…Monocytic acute myeloid leukemia (AML) responds poorly to current treatments, including venetoclax-based therapy. We conducted in vivo and in vitro CRISPR-Cas9…”
Get full text
Journal Article -
11
Abstract 1383: A CRISPR-Cas9 tiling screen to identify functional domains within DNMT1 and/or DNMT3B that can be targeted for therapeutic intervention in AML
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract DNA methylation is an epigenetic mechanism that regulates gene expression during many stages of development, including genomic imprinting, stem cell…”
Get full text
Journal Article -
12
Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
Published in Nature communications (20-02-2017)Get full text
Journal Article -
13
The Pro-Tumorigenic Vascular Niche Sustains the T-Cell Acute Lymphoblastic Leukemia Phenotype and Fosters Resistance to Therapy
Published in Blood (02-12-2016)“…Introduction. T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous malignancy associated with a high risk of treatment failure. Efforts…”
Get full text
Journal Article -
14
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Published in Cancer cell (11-05-2015)Get full text
Journal Article -
15
Convergent Mutations and New Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Published in Blood (06-12-2014)“…Introduction. If the role of ALK chimeras is well known in the pathogenesis of ALK+ Anaplastic Large Cell Lymphoma (ALCL), the mechanisms leading to the…”
Get full text
Journal Article -
16
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma
Published in Frontiers in oncology (2012)“…The discovery by Morris et al. (1994) of the genes contributing to the t(2;5)(p23;q35) translocation has laid the foundation for a molecular based recognition…”
Get full text
Journal Article